Pharmanutra S.p.A. (BIT:PHN)
Italy flag Italy · Delayed Price · Currency is EUR
50.20
+0.55 (1.11%)
Apr 1, 2025, 3:40 PM CET

Pharmanutra Statistics

Total Valuation

Pharmanutra has a market cap or net worth of EUR 483.04 million. The enterprise value is 478.22 million.

Market Cap 483.04M
Enterprise Value 478.22M

Important Dates

The last earnings date was Friday, March 14, 2025.

Earnings Date Mar 14, 2025
Ex-Dividend Date May 5, 2025

Share Statistics

Pharmanutra has 9.60 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class n/a
Shares Outstanding 9.60M
Shares Change (YoY) -0.61%
Shares Change (QoQ) -0.27%
Owned by Insiders (%) 10.74%
Owned by Institutions (%) 15.73%
Float 4.26M

Valuation Ratios

The trailing PE ratio is 29.10 and the forward PE ratio is 22.69.

PE Ratio 29.10
Forward PE 22.69
PS Ratio 4.16
PB Ratio 7.77
P/TBV Ratio 11.82
P/FCF Ratio 29.73
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.58, with an EV/FCF ratio of 29.43.

EV / Earnings 28.79
EV / Sales 4.12
EV / EBITDA 15.58
EV / EBIT 17.48
EV / FCF 29.43

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.39.

Current Ratio 2.38
Quick Ratio 1.95
Debt / Equity 0.39
Debt / EBITDA 0.79
Debt / FCF 1.49
Interest Coverage 25.76

Financial Efficiency

Return on equity (ROE) is 28.39% and return on invested capital (ROIC) is 20.25%.

Return on Equity (ROE) 28.39%
Return on Assets (ROA) 14.88%
Return on Invested Capital (ROIC) 20.25%
Return on Capital Employed (ROCE) 30.36%
Revenue Per Employee 984,305
Profits Per Employee 140,754
Employee Count 118
Asset Turnover 1.01
Inventory Turnover 7.53

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.25% in the last 52 weeks. The beta is 0.32, so Pharmanutra's price volatility has been lower than the market average.

Beta (5Y) 0.32
52-Week Price Change -13.25%
50-Day Moving Average 52.60
200-Day Moving Average 52.74
Relative Strength Index (RSI) 39.79
Average Volume (20 Days) 15,814

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Pharmanutra had revenue of EUR 116.15 million and earned 16.61 million in profits. Earnings per share was 1.73.

Revenue 116.15M
Gross Profit 59.24M
Operating Income 27.36M
Pretax Income 27.16M
Net Income 16.61M
EBITDA 30.24M
EBIT 27.36M
Earnings Per Share (EPS) 1.73
Full Income Statement

Balance Sheet

The company has 29.10 million in cash and 24.27 million in debt, giving a net cash position of 4.83 million or 0.50 per share.

Cash & Cash Equivalents 29.10M
Total Debt 24.27M
Net Cash 4.83M
Net Cash Per Share 0.50
Equity (Book Value) 62.20M
Book Value Per Share 6.48
Working Capital 37.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.50 million and capital expenditures -4.25 million, giving a free cash flow of 16.25 million.

Operating Cash Flow 20.50M
Capital Expenditures -4.25M
Free Cash Flow 16.25M
FCF Per Share 1.69
Full Cash Flow Statement

Margins

Gross margin is 51.00%, with operating and profit margins of 23.56% and 14.30%.

Gross Margin 51.00%
Operating Margin 23.56%
Pretax Margin 23.39%
Profit Margin 14.30%
EBITDA Margin 26.04%
EBIT Margin 23.56%
FCF Margin 13.99%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.01%.

Dividend Per Share 1.00
Dividend Yield 2.01%
Dividend Growth (YoY) 17.65%
Years of Dividend Growth 4
Payout Ratio 49.20%
Buyback Yield 0.61%
Shareholder Yield 2.62%
Earnings Yield 3.44%
FCF Yield 3.36%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Pharmanutra has an Altman Z-Score of 7.99.

Altman Z-Score 7.99
Piotroski F-Score n/a